Prescription drug pricing; prohibiting certain action. Effective date.

SB 1030, the "340B Drug Pricing Nondiscrimination Act," prohibits health insurers, pharmacy benefits managers, and third-party payors from discriminating against Oklahoma's 340B drug program participants. It requires equal reimbursement rates for 340B drugs compared to non-340B drugs and bans special fees, billing requirements, or restrictions solely because a provider participates in the federal 340B program. The bill also prevents interference with patients' choice to receive 340B drugs at participating pharmacies and prohibits requiring special billing modifiers for 340B claims unless mandated by federal programs. This directly affects hospitals, clinics, and pharmacies enrolled in the federal 340B program, as well as insurers and pharmacy benefit managers handling their claims.